Copy number alterations (CNAs) are a hallmark of cancer. Large-scale cancer genomic studies have already established the CNA landscape of most human tumor types and some CNAs are recognized as cancer-driver events. However, their precise role in tumorigenesis as well as their clinical and therapeutic relevance remain undefined, thus computational and statistical approaches are required for the biological interpretation of these data. Here, we describe CNApp, a user-friendly web tool that offers sample-and cohort-level association analyses, allowing a comprehensive and integrative exploration of CNAs with clinical and molecular variables. CNApp generates genome-wide profiles, calculates CNA levels by computing broad, focal and global CNA scores, and uses machine learning-based predictions to classify samples by using segmented data from either microarrays or next-generation sequencing. In the present study, using copy number data of well-annotated 10,635 genomes from The Cancer Genome Atlas spanning 33 cancer subtypes, we showed that patterns of CNAs classified tumor subtypes according to their tissue-of-origin and that broad and focal CNA scores correlated positively in those samples with low levels of chromosome and arm-level events.
INTRODUCTION
The presence of somatic copy number alterations (CNAs) is a ubiquitous feature in cancer. Indeed, the distribution of such CNAs is sufficiently tissue-specific to distinguish and enable the classification of tumor entities (Ried et al. 2012; Taylor et al. 2018a) , and may allow identifying groups of tumors responsive to particular therapies (Cairncross et al. 2013; Davoli et al. 2017) . Moreover, high levels of CNAs, which result from aneuploidy and chromosome instability, are generally associated with high-grade tumors and poor prognosis (Sansregret et al. 2018) . Two main subtypes of CNAs can be discerned: broad CNAs, which are defined as whole-chromosome and chromosomal armlevel alterations, and focal CNAs, which are alterations of limited size ranging from part of a chromosome-arm to few kilobases (Krijgsman et al. 2014; Zack et al. 2013) .
Recently, it has been uncovered that while focal events mainly correlate with cell cycle and proliferation markers, broad aberrations are mainly associated with immune evasion markers (Taylor et al. 2018b; Davoli et al. 2017; Buccitelli et al. 2017) . Nevertheless, the precise role of CNAs in tumor initiation and progression, as well as their clinical relevance and therapeutic implications remain still poorly understood.
Characterization and interpretation of CNAs is time-consuming and very often requires complex integrative analyses with clinical and molecular information. Moreover, visualization of complex data is usually essential to discriminate key results. Wellestablished CNA algorithms, such as the gold-standard circular binary segmentation, determine the genomic boundaries of copy number gains and losses based on signal intensities or read depth obtained from array comparative genomic hybridization and SNP-array or next-generation sequencing data, respectively (Olshen et al. 2004 ).
Variability within gain or loss levels can be addressed with the algorithm CGHcall, which enables the identification of single copy number changes (van de Wie et al. 2007) . In order to overcome the complex nature of tumor samples (Stratton et al. 2009 ), more recent segmentation methods improved the accuracy to identify copy number segments either by considering the B allele frequency (BAF), such as ExomeCNV (Sathirapongsasuti et al. 2011) , Control-FREEC (Boeva et al. 2012 ) and SAAS-CNV (Zhang and Hao 2015) , or through adjusting by sample purity and ploidy estimates, such as GAP (Popova et al. 2009 ), ASCAT (Van Loo et al. 2010 ) and ABSOLUTE (Carter et al. 2012) . However, the state-of-the-art computational approach for CNA analysis is GISTIC2.0 (Mermel et al. 2011) , which is a gene-centered probabilistic method that enables to define the boundaries of recurrent putative driver CNAs in large cohorts (Beroukhim et al. 2010) . Nevertheless, despite ongoing progress on identifying CNAs, to our knowledge there is no bioinformatic tool readily available for integrative analyses to unveil the biological interpretation of these CNAs.
To address this issue, we developed CNApp, the first open-source application to comprehensively analyze and integrate CNA profiles with molecular and clinical variables. CNApp was built in Shiny R package (Chang et al. 2018 ) and provides the user with high-quality interactive plots and statistical correlations between CNAs and annotated variables in a fast and easy-to-explore interface. In particular, CNApp uses genomic segmented data to quantify CNA levels based on broad and focal genomic alterations, assess differentially altered genomic regions, and perform machine learningbased predictions to classify tumor samples. A dataset including 160 colon cancer samples with clinical annotation is loaded for demonstration purposes. To exemplify the applicability and performance of CNApp, we used publicly available segmented data from The Cancer Genome Atlas (TCGA) to (i) measure the burden of global, broad, focal CNAs as well as generate CNA profiles in a pan-cancer dataset spanning 33 cancer subtypes, (ii) identify cohort-based recurrent CNAs in hepatocellular carcinoma and compare it with previously reported data using different methods, and (iii) assess predicting models for colon cancer molecular subtype and microsatellite instability status classification based on CNA scores and specific genomic imbalances. CNApp is hosted at http://bioinfo.ciberehd.org/CNApp and the source code is freely available at GitHub (https://github.com/ait5/CNApp).
RESULTS

Implementation and basic usage
Functions of CNApp comprise three main sections: 1-Re-Seg & Score: re-segmentation, CNA scores computation and variable association, 2-Region profile: genome-wide CNA profiling, and 3-Classifier model: machine learning classification model predictions, (Figure 1 ). Each of these sections and their key functions are described below. The input file consists of a data frame with copy number segments provided by any segmentation algorithm. Mandatory fields and column headers are sample name (ID), chromosome (chr), start (loc.start) and end (loc.end) genomic positions, and the log2 ratio of the copy number amplitude (seg.mean) for each segment. If available, it is recommended to include sample purity (purity) and BAF values (BAF), which can improve the accuracy of CNA calls and will provide information of copy number neutral loss-of-heterozygosity (CN-LOH) events. Annotation of variables can be included in the input file (tagged in every segment from each sample) or by loading an additional file specifying new variables to every sample. Section 1. Re-Seg & Score: re-segmentation, CNA scores computation and variable association First, CNApp applies a re-segmentation approach aiming at correcting potential background noise and amplitude divergence due to technical variability. Default resegmentation settings include minimum segment length (100 Kbp), maximum distance between segments (1 Mbp), maximum amplitude (seg.mean) deviation between segments (0.16), minimum amplitude (seg.mean) deviation from segment to zero (0.16), and maximum BAF deviation between segments (0.1). These parameters can be customized by the user to better adjust the re-segmentation and CNA calling for each particular dataset. Re-segmented data are then used to calculate the focal (FCS), broad (BCS) and global (GCS) CNA scores, which provide three different quantification of CNA levels for each sample. To compute these scores, CNApp classifies and weights CNAs based on amplitude and length. A weight is given to each segment according to its seg.mean value and by applying low-, medium-and high-level copy number amplitude thresholds. By considering the relative length of each segment to the whole-chromosome or chromosome arm, segments are tagged as chromosomal -by default, 90% or more of the chromosome affected-, as arm-level -50% or more of the chromosome arm affected-, or as focal -less than 50% of the chromosome arm affected. Percentages for relative lengths are also customizable. For each sample, BCS is computed by considering chromosome and armlevel segment weights according to the amplitude value. Likewise, calculation of FCS takes into account weighted focal CNAs and the amplitude and length of the segment.
Finally, GCS is computed by considering the sum of normalized FCS and BCS values, providing an overall assessment of the CNA burden for each sample. To assess the reliability of CNA scores, we compared each score with the corresponding fraction of altered genome using a TCGA pan-cancer set of 10,635 samples. Both FCS (values ranging from 5 to 2,466) and BCS (ranging from 0 to 44) highly correlated with the fraction of altered genome by focal and broad copy number changes, respectively (Spearman's rank correlation for BCS = 0.957 and for FCS = 0.938) (Supplemental_Fig_S1 A and B). As expected, GCS (values ranged from -1.93 to 12.60) highly correlated with the fraction of altered genome affected by both focal and broad CNAs (Spearman's rank correlation for GCS = 0.963) (Supplemental_Fig_S1C).
Additionally, parametric and non-parametric statistical tests are used to establish associations between CNA scores and annotated variables from the input file.
Section 2. Region profile: genome-wide CNA profiling
This section utilizes re-segmented data obtained from section 1 or uploaded segmented data without re-segmentation to generate genomic region profiling and sample-to-sample correlations. To conduct this, re-segmented data are transformed into genome region profiles according to a user-selected genomic window (i.e., chromosome arms, half-arms, cytobands, sub-cytobands or 40-1 Mbp windows). All segments, or either only broad or only focal can be selected for this analysis. Length-relative means are computed for each window by considering amplitude values from those segments included in each specific window. Default thresholds for low-level copy number gains and losses (i.e., |0.2|) are used as cutoffs to classify genome regions and to calculate their frequencies in this section. Genome-region profiles are presented in genome-wide heatmaps to visualize general copy number patterns. Up to six annotation tracks can be added and plotted simultaneously allowing visual comparison and correlation between CNA profiles and different variables, including the CNA scores obtained in section 1. Generation of hierarchical clusters by samples and regions is optional. CNA frequency summaries by genomic region and by sample are represented as stacked bar plots. Importantly, assessing differentially altered regions between sample groups might contribute to discover genomic regions associated with annotated variables and thus unveil the biological significance of specific CNAs. To do so, CNApp interrogates descriptive regions associated with any sample-specific annotation variable provided in the input file. Student's t-test or Fisher's test are applied when considering CNAs as continuous alterations (seg.mean values) or as categorical events (presence of gains and losses), respectively. Default statistical significance is set to P-value lower than 0.1. However, p-value thresholds can be defined by the user and adjusted P-value is optional.
A heatmap plot allows the visualization and interpretation of which genome regions are able to discriminate between sample groups. By selecting a region of interest, box plots and stacked bar plots are generated comparing seg.mean values and alteration counts in Student's t-test and Fisher's test tabs, respectively. Additionally, genes comprised in the selected region are indicated.
Classifier model: Machine learning classification model predictions
This section allows the user to generate machine learning-based classifier models by choosing a variable to define sample groups and one or multiple classifier variables. To do so, CNApp incorporates the randomForest R package (Liaw and Wiener 2002) . The model construction is performed 50-times and bootstrap set is changed in each iteration.
By default, only annotation variables from the input file are loaded to work either by group defining or by classifier variables. If Re-Seg & Score and/or Region profile sections have been previously completed, the user can upload data from these sections (i.e., CNA scores and genomic regions). Predictions for the model performance are generated and the global accuracy is computed along with sensitivity and specificity values by group.
Classifier models can be useful to point out candidate clinical or molecular variables to classify sample subgroups. A summary of the data distribution and plots for real and model-predicted groups are visualized. A table with prediction rates throughout the 50times iteration model and real tags by sample is displayed and can be downloaded.
Genomic characterization of cancer subtypes
First, we evaluated the capacity of CNApp to analyze and classify cancer subtypes according to distinct patterns of CNA scores, and assess whether CNApp was able to reproduce the distribution of cancer subtypes based on specific CNA profiles. To do so, level 3 publicly available Affymetrix SNP 6.0 array data from 10,635 tumor samples spanning 33 cancer types from TCGA pan-cancer database were used. We applied Re-Seg & Score and Region profile using default parameters to obtain re-segmented data, CNA scores, and cancer-specific CNA profiles. Correlations between CNA scores were assessed by computing Spearman's rank test, obtaining values of 0.59 between BCS and FCS, 0.90 between BCS and GCS, and 0.85 between FCS and GCS. In addition, we further assessed the correlation between BCS and FCS for each individual BCS value.
While tumors with low BCS displayed a positive correlation between broad and focal alterations, tumors did not maintain such correlation in higher BCS values (Supplemental_Fig_S2A). BCS, FCS and GCS distributions across cancer subtypes supported the existence of distinct CNA levels between tumors from different origin ( Figure 2A ). While cancer subtypes such as acute myeloid leukemia (LAML), thyroid carcinoma (THCA) or thymoma (THYM) showed low levels of broad and focal events (GCS median values of -1.67 for LAML, -1.68 for THCA, and -1.52 for THYM), uterine carcinosarcoma (UCS), ovarian cancer (OV) and lung squamous cell carcinoma (LUSC) displayed high levels of both types of genomic imbalances (GCS median values of 2.55, 2.44, and 0.97 for UCS, OV, and LUSC, respectively). Some cancer subtypes displayed a preference for either broad or focal copy number alterations. For example, kidney chromophobe (KICH) tumors showed the highest levels of broad events (median BCS value of 27); however, they were amongst those subtypes with less focal CNAs (median Subsequent analysis aimed at generating genome-wide patterns for each cancer subtype based on chromosome-arm genomic windows and the overall corresponding frequencies ( Figure 2B ). We found that chromosome arms altered in more than 25% across all samples were 1q, 7p, 7q, 8q and 20q for copy number gains, and 8p and 17p for copy number losses. Conversely, chromosome arms affected by CNAs in less than 10% of all cancer subtypes included 2q and 19p ( Figure 2C ). By using a subset of 20 out of the 33 cancer types for which tumor type information was available, we asked CNApp to compute the average arm-region for each cancer type to assess if they clustered according to their CNA profile (Supplemental_Fig_S2B). Our analysis showed that correlation profiles resulting from Pearson's test were hierarchically clustered according to their tumor type ( Figure 2D ). Gastrointestinal (colon, rectum, stomach and pancreatic), gynecological (ovarian and uterine) and squamous (cervical, head and neck, and lung) cancers clustered together based on specific CNA profiles for each group ( Figure S2B ).
These results strongly correlated with previously reported findings (Taylor et al. 2018b; Hoadley et al. 2018) .
Identification of recurrent CNAs in liver hepatocellular carcinoma
Next, we attempted to test the ability of CNApp to identify recurrent broad and focal CNAs in a large cohort of samples. For that reason, we chose to perform CNA analysis of 370 samples from TCGA corresponding to the Liver Hepatocellular Carcinoma (LIHC) cohort, robustly reproducing previous findings reported by GISTIC2.0 (Ally et al. 2017) . The overall pattern of recurrent broad and focal CNAs described in the TCGA study was similar to earlier reports, confirming the specific copy number profile for hepatocellular carcinoma (HCC) (Chiang et al. 2008; Guichard et al. 2012; Wang et al. 2013; Totoki et al. 2014; Schulze et al. 2015) . By using GISTIC2.0, the most frequent broad alterations in LIHC were gains at 1q (61%) and 8q (52%), and losses at 8p (70%) and 17p (56%) (Supplemental_Table_S1). Recurrent focal amplifications involved the well-characterized driver oncogenes CCND1 and FGF19 (11q13.3), MYC (8q24.21), MET (7q31.2), VEGFA (6p21.1) and MCL1 (1q21.3), and the most recurrent deletions included tumor suppressor genes such as RB1 (13q14.2) and the CDKN2A (9p21.3) genes (Supplemental_Table_S2).
By applying the default parameters of CNApp to the LIHC dataset and selecting chromosome arms as genomic regions to assess broad events, we consistently found copy number gains at 1q (56%) and 8q (46%), and copy number losses at 8p (62%) and 17p (47%) as the most frequent alterations ( Figure 3A) . The slightly lower rate tendency of broad CNAs from CNApp as compared to GISTIC2.0 also appeared in the subsequent recurrent broad alterations (Supplemental_Table_S1). For instance, GISTIC2.0 significantly detected gains with rates between 25-40% on eight additional chromosomearms, including 5p, 5q, 6p, 20p, 20q, 7p, 7q, and 17q, which were identified by CNApp in 20-30% of the samples. Similarly, GISTIC2.0 significantly detected broad deletions at frequencies between 20-40% on 18 additional chromosome-arms, of which 4q, 6q, 9p, 13q, 16p, and 16q losses were observed at ≥20% by CNApp, and the rest of them displayed rates between 10-20%. In this case, discrepancies in CNA frequencies were expected considering the lower copy number amplitude thresholds used by GISTIC2.0 in comparison with the CNApp default cutoffs (|0.1| vs |0.2|, corresponding to ~2.14/1.8 copies vs 2.3/1.7 copies, respectively). Indeed, previous reports analyzing CNAs in other HCC cohorts and using greater copy number thresholds, showed frequencies of alterations similar to those estimated by CNApp (Chiang et al. 2008; Guichard et al. 2012; Wang et al. 2013; Schulze et al. 2015) . To assess the impact of modifying CNApp amplitude thresholds, we next re-run the software dropping the minimum copy number values to |0.1|. As expected, the overall number of broad alterations increased, reaching frequency values similar or even higher than those reported by GISTIC2.0 ( Figure 3B and Supplemental_Table_S1). Of note, such drop from 0.2 to 0.1 might facilitate the identification of subclonal genomic imbalances, which are very frequent among tumor samples (McGranahan and Swanton 2017), though it can also increase the number of false positive calls. Furthermore, we assessed whether the identification of broad events was affected by two additional parameters: (i) the relative length to classify a segment as armlevel alteration, and (ii) the re-segmentation provided by CNApp. As expected, increasing the percentage of chromosome arm required to classify a CNA segment as arm-level (from ≥ 50% to ≥ 70%) or skipping the re-segmentation step led to an underestimation of some broad events, whereas decreasing the percentage of chromosome arm (from ≥50% to ≥40%) resulted in the opposite (Supplemental_Fig_S3A-C and Supplemental_Table_S1).
As far as focal CNAs are concerned, CNApp and GISTIC2.0 use different strategies to quantify their recurrence. Therefore, the comparison between the two methods was evaluated in a more indirect manner. GISTIC2.0 constructs minimal common regions (also known as 'peaks') that are likely to be altered at high frequencies in the cohort, which are scored using a Q-value and may present a wide variety of genomic lengths (Mermel et al. 2011 CDKN2A) , which are in agreement with previous studies in HCC ( Figure 3C and Supplemental_Table_S2) (Chiang et al. 2008; Guichard et al. 2012; Wang et al. 2013; Schulze et al. 2015) .
Compared to GISTIC2.0, CNApp reported 14 of the 27 significant amplifications and 14 of the 34 significant deletions at rates >10%, and the remaining alterations displaying rates between 4-10% (Supplemental_Table_S3) ). Most importantly, regions with the highest frequency detected by CNApp showed a good match with lowest GISTIC2.0 Q-residual values, indicating that the most significant 'peaks' identified by GISTIC2.0 were actually included in the most recurrently altered sub-cytobands reported by CNApp.
As previously suggested, recurrent focal alterations often occur at lower frequencies than broad events (Beroukhim et al. 2010) . However, previous studies describing the genomic landscape of HCC mostly focused on high-level focal CNAs (from >3 copies for gains and from <1.3 copies for losses), thus reporting lower frequencies than those estimated by CNApp (Chiang et al. 2008; Guichard et al. 2012; Schulze et al. 2015) . Interestingly, excluding the low-level alterations and evaluating only the moderate and high-amplitude events (≥3 and ≤1 copies), frequencies dropped to values closer to those previously reported ( Figure 3D and Supplemental_Table_S2). Amplifications reached maximum rates of 11%, whereas losses ended up at rates of ~2%, in consistence with the observation that high-level CNAs are relatively rare (Zack et al. 2013 Ried et al. 1996; Meijer et al. 1998; Nakao et al. 2004 ). By assessing the broad CNA events in the entire cohort, we observed that the most frequently altered chromosome arms were gains of 7p, 7q, 8q, 13q, 20p, and 20q, and losses of 8p, 17p, 18p, and 18q, occurring in more than 30% of the samples ( Figure 4A ). Focal CNAs were obtained by generating genomic regions by sub-cytobands. Of note, five out of six genomic losses and five out of 18 genomic gains contained deletions and amplifications, respectively, identified by GISTIC2.0 in the COAD TCGA cohort.
Subsequently, we performed integrative analysis of genomic imbalances, CMS groups, and CNA scores. By using CNApp, we assessed whether CNA scores were able to classify colon cancer samples according to their CMS. While BCS established significant differences between CMS paired comparisons (P ≤ 0.0001, Student's t-test), FCS poorly discern CMS1 from 3 and CMS2 from 4 ( Figure 4B and Supplemental_Fig_S4A) . Thus, we reasoned that broad CNAs rather than focal were able to better discriminate between different CMS groups. In fact, the distribution of CMS groups based on BCS resembled the distribution of somatic CNA counts defined by GISTIC2.0 (Guinney et al. 2015) , which agrees with the observation that BCS highly correlates with the fraction of altered Figure 4D ). These disparities are of utmost importance since recent studies reported that high copy number alterations correlate with reduced response to immunotherapy (Davoli et al. 2017) . Importantly, it has been suggested that MSI status might be predictive of positive immune checkpoint blockade response in advanced CRC, probably due to the low levels of CNA usually presented by MSI tumors (Le et al. 2015) .
We next asked CNApp to compare genomic regions differentially represented in the four CMS groups based on a Student's t-test or Fisher's test with adjusted p-value. By applying a Student's t-test, we could observe that CMS1 resembled CMS3, except for the gain of chromosome 7 and the loss of 18q, which were the alterations that commonly appeared in CMS3 samples with BCS above 4 (P ≤ 0.001, Student's t-test) (Supplemental_Fig_S4B). Even though only subtle CNA differences between CMS2 and CMS4 were identified, the loss of 14q was significantly more detected in CMS2 (42%) than in CMS4 (17.1%) (P ≤ 0.005, Student's t-test) (Supplemental_Fig_S4B). Visually exploring the heatmap plot and further analyzing specific regions, we observed that the gain of 12q was more frequently associated with CMS1 than CMS2 (P ≤ 0.005, Student's t-test), in agreement with previous studies reporting that the gain of chromosome 12 is associated with microsatellite unstable tumors (Supplemental_Fig_S4B) (Trautmann et al. 2006) . Intriguingly, the gain of the chromosome arm 20q alone mimicked the distribution of somatic CNAs defined by GISTIC2.0 across consensus subtype samples ( Figure 4E ) (Guinney et al. 2015) . In fact, chromosome arm 20q was gained in 99.1%, 70.7%, 39.2%, and 10.9% of CMS2, CMS4, CMS3 and CMS1 tumors, respectively.
Finally, we applied machine learning-based prediction models to classify samples by their MSI status or CMS. BCS predicted MSI status with a global accuracy of 82.2%. This was consistent with the fact that BCS was able to distinguish CMS1 from CMS2 with 89.2% of accuracy. However, when we tested the performance of BCS to predict any CMS group, the accuracy was only 47.5%, indicating that BCS alone is a poor predictive variable to assess CMS. We then used the most discriminative descriptive regions among CMS groups (i.e., 13q, 17p, 18, and 20q), and reached an accuracy to correctly predict CMS of 55%. In fact, the occurrence of these genomic alterations was able to differentiate CMS2 from CMS4 with an accuracy of 70%, and CMS1 from CMS3 with a 72.3%
accuracy. As expected, this set of genomic alterations distinguished CMS1 from CMS2 samples with an accuracy of 95%. Altogether, these data suggest that CNApp might provide insight into further classifying CRC samples in CMS groups.
DISCUSSION
Here we present CNApp, a web-based computational approach to analyze and integrate CNAs associated with molecular and clinical variables. CNApp calculates CNA scores to quantify focal, broad and global levels of alterations for each individual sample after an optional process of re-segmentation. Moreover, CNApp utilizes genomic imbalances selected by the user to assess classifier variables by computing machine learning-based models. Although CNApp has been developed using segmented genomic copy number data obtained from SNP-arrays, the software is also able to accommodate segmented data from next-generation sequencing.
Overall, CNApp was benchmarked by analyzing a pan-cancer TCGA dataset with more than 10,000 samples, being able to cluster major tumor types according to CNA patterns.
Moreover, our results demonstrate the reliability of CNApp in identifying regions encompassing the most recurrent CNAs. The software successfully reproduced the wellcharacterized genomic profile of HCC and CRC, considering both broad and focal events.
Although CNApp has not been developed to define the precise boundaries of focal events, the software is capable to detect which regions are likely to contain the most recurrent alterations. However, we acknowledge that the characterization of focal alterations potentially containing driver events performed by GISTIC2.0 is more accurate than the genomic windows provided by CNApp. Thus, despite the in-depth comparison described here, we consider CNApp as a complementary tool rather than a replacement for GISTIC2.0.
Finally, applying CNApp to a colon cancer dataset for which clinical features were known allowed the determination of a BCS value of 4 to potentially discriminate MSI from MSS tumors. Most importantly, due to the inverse correlation between MSI and aneuploidy in CRC, our results suggest that this BCS value could be established as a cutoff to define the edge between low and high aneuploid tumors. Nevertheless, these results ought to be further validated in an independent cohort. Since high levels of aneuploidy correlate with immune evasion markers, quantification of CNAs and their association with molecular and clinical features might be of extreme relevance. In fact, specific genomic regions defined by CNApp contributed to classify the consensus molecular subtypes. This is of clinical interest as it is known that CMS1 microsatellite unstable tumors might show a positive response to immuno-related treatments. Therefore, we believe that CNApp enables not only the fundamental analysis of CNA profiles, but also the functional understanding of CNAs in the context of clinical samples and their potential use as biomarkers.
METHODS
Data set availability
CNA data from TCGA: pan-cancer cohort Affymetrix SNP6.0 array copy number segmented data (Level 3) 
Software and tool availability
CNApp can be accessed at http://bioinfo.ciberehd.org/CNApp. It was developed using Shiny R package (version 1.1.0), from R-Studio (Chang et al. 2018) . The tool was applied and benchmarked while using R version 3.4.2 (2017-09-28) --"Short Summer". List of packages, libraries and base coded are freely available at GitHub, and instructions for local installation are also specified. 
CNA scores computation
Genomic windows computation
Region profiling section allows genome segmentation analysis by user-selected windows (i.e. arms, half-arms, cytobands, sub-cytobands, and 40Mb till 1Mb). In order to do that, windows files were generated for each option and genome build (hg19 and hg38).
Cytobands file cytoBand.txt from UCSC page and for both genome builds was used as mold to compute regions (Casper et al. 2017 
Machine learning-based classifier models
We used the randomForest R package (Liaw and Wiener 2002) to compute machine learning classifier models. Variables to define sample groups must be selected, as well as at least one classifier variable. Model construction is performed 50-times and training set is changed by iteration. In order to compute model and select training set, multiple steps and conditions have to be accomplished:
i. total N samples divided by G groups depicted by group-defining variable must be higher than n samples from the smaller group: = ; >
ii. If condition above is not accomplished, then P is set to 75% of n:
if ≤ then = · 0.75 iii. P term must be higher than one, and N must be equal or higher than 20:
> 1 or ≥ 20 iv. Classifier variables, when categorical, shall not have higher number of tags (Z) than groups defined (G) by group-defining variable:
< v.
Training set (T) is computed and merged for each group (g) from groups (G) defined by group variable, extracting P samples from g as follows:
( ) = samples from = ( * *,-After model computation, contingency matrix with prediction and reference values by group is created to compute accuracy, specificity and sensitivity by group.
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Figure 4: Genomic characterization of colon cancer according to the CMS
